7.34
price down icon8.82%   -0.71
after-market Handel nachbörslich: 7.71 0.37 +5.04%
loading

Finanzdaten der Lipocine Inc-Aktie (LPCN)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
899.69%
1.1454
0.1146 0.6228 0.0939 3.4914
Operating Expenses
5.34%
3.6612
3.4756 3.0272 2.184 1.9459
Benefits Costs and Expenses
6.48%
3.5155
3.3014 2.8286 1.9585 1.7092
Costs And Expenses
16.07%
2.9171
3.4756 2.8286 1.9585 0.7819
Depreciation and Amortization
6.08%
0.015
0.0141 0.0161 0.0156 0.0156
Operating Income/Loss
25.15%
-2.5158
-3.361 -2.4044 -2.0902 1.5455
Nonoperating Income/Loss
16.35%
0.1457
0.1742 0.1986 0.2255 0.2367
Income/Loss From Continuing Operations Before Tax
25.63%
-2.3701
-3.1868 -2.2057 -1.8647 1.7822
Income/Loss From Continuing Operations After Tax
25.62%
-2.3703
-3.1868 -2.2057 -1.8649 1.7815
Net Income/Loss
25.63%
-2.3701
-3.1868 -2.2057 -1.8649 1.7822
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
98.57%
0.0774
5.4131 5.352 5.3486 0.00302
Diluted Average Shares
93.78%
0.3368
5.4131 5.352 5.3486 0.0867
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$45.65
price down icon 0.48%
$28.06
price down icon 1.72%
$52.56
price down icon 1.55%
$91.19
price up icon 1.21%
$139.50
price down icon 0.01%
biotechnology ONC
$284.05
price down icon 0.44%
Kapitalisierung:     |  Volumen (24h):